What is treatment without surgery

MIBRAR® (Minimally Invasive Biological Regenerative Approach) is a patented regenerative medicine protocol. Instead of surgically removing damaged tissue, the method launches its own restoration using the patient's cells and growth factors.

A needle instead of a scalpel

The biological product is delivered into damaged tissue through a fine needle under ultrasound and optical navigation (Sono-Control Arm + Cyber-Navi-Hand). Millimeter precision.

Your own cells instead of an implant

Only autologous materials are used: PRP and CGF from blood, Lipogems® and SVF from fat, BMAC from bone marrow. No risk of immune rejection.

Local anesthesia instead of general

The procedure is performed under local anesthesia. The patient is awake, communicates with the doctor, sees the navigation on the screen.

Outpatient instead of hospitalization

After 1–2 hours of observation the patient goes home. No ward, no IV drips, no dressing changes. Return to light daily activity — the same day.

2–4 weeks of rehab instead of 6–12

No postoperative wound, no immobilization-related muscle atrophy. Rehab is short and gentle: physio, moderate loading, gradual return to sport.

Regeneration, not pain masking

NSAIDs and steroid blocks relieve symptoms but accelerate tissue destruction. MIBRAR® restores the tissue itself — cartilage, ligament, disc annulus fibrosus.

When non-surgical treatment helps

Spine

Disc herniation and protrusion without absolute surgical indications. Radiculopathy, sciatica, facet syndrome. Osteochondrosis, stable spondylolisthesis grade I–II. Mild to moderate canal stenosis. Failed back surgery syndrome.

Large joints

Arthrosis stage I–III (knee, shoulder, hip, ankle). Meniscal and rotator cuff injuries. Impingement, frozen shoulder, calcifying tendinitis. Chondromalacia, chondral defects.

Small joints and ligaments

Rhizarthrosis, carpal tunnel syndrome, de Quervain's tenosynovitis. Plantar fasciitis, Achilles tendinopathy, hallux rigidus. Runner's injuries, patellar tendinopathy, "tennis elbow."

When surgery is still required

MIBRAR® is not a replacement for surgery in all cases. There are conditions where delay is dangerous. We will tell you honestly if a case is surgical.

Absolute surgical indications

Cauda equina syndrome (acute pelvic organ dysfunction). Progressive motor deficit. Acute spinal cord compression. Unstable fractures. Complete tears of major ligaments with loss of function.

Terminal arthrosis stages

Stage IV with complete cartilage loss, axis deformity, bone cysts. Endoprosthesis provides fast and predictable results; MIBRAR® here is only palliative in select cases.

What we do in such cases

Explain the situation in detail at consultation. Provide a "second opinion." Refer to a surgeon if needed. After surgery, MIBRAR® is often used to accelerate recovery.

How the treatment works

1. Remote consultation

The patient sends MRI and a description of complaints. Within 1–3 business days they receive a preliminary opinion: whether the method is suitable, the plan and estimated timeline.

2. In-person visit in Munich

Examination, ultrasound, plan refinement. 60–90 minutes. Procedure date and protocol are confirmed.

3. Biomaterial harvest and product preparation

Blood, fat or bone marrow (per protocol). CGF, PRP, Lipogems® or SVF are prepared in-clinic using patented protocols.

4. Injection under navigation

30–60 minutes. Precise delivery under ultrasound and optical navigation into the damage zone. Local anesthesia.

5. 1–2 hours of observation and home

We check on the patient and provide recommendations. Home or hotel the same day. Light activity the next day.

6. Follow-up at 3 and 6 months

MRI or ultrasound + clinical exam. We assess tissue regeneration and function. Additional session if needed.

Biological MIBRAR® products

All products are autologous (from the patient's own tissue). Choosing the specific product or combination is the doctor's task after MRI and examination.

PRP

Platelet-rich plasma. Harvest — blood from a vein. Mild/moderate arthrosis, tendinopathies, acute ligament injury.

CGF

Concentrated growth factors in a fibrin matrix. A more advanced PRP form. Moderate arthrosis, chronic tendinopathies, disc herniation.

Lipogems® Ortho

Mechanically processed adipose tissue — a source of mesenchymal cells and pericytes. No enzymatic processing. Moderate/severe arthrosis, disc herniation, large defects.

SVF and BMAC

Stromal vascular fraction from fat and bone marrow aspirate concentrate. High cellularity. Severe degeneration, failed back surgery, osteonecrosis, bony defects.

Expected results

2–4×VAS pain reduction
70–80%Patients avoid surgery
3 moPeak effect
25,000+Procedures over 25 years

No method in medicine offers guarantees. Efficacy depends on disease stage, age, comorbidities and adherence to recommendations.

Find out if the method is right for you

Upload MRI and a short complaint description — receive a free preliminary opinion.

Submit a request

Frequently asked questions

When can surgery be avoided?

In most cases of stage I–III arthrosis, herniations without absolute indications, tendinopathies. Absolute surgical indications remain.

What is regenerative medicine?

A branch that restores tissue through the patient's own cells and growth factors instead of replacing it with an implant.

What results can be expected?

Pain reduction 2–4× on VAS, return to activity, slowing or stopping degeneration.

Is hospitalization required?

No. All MIBRAR® procedures are outpatient. The patient goes home on the same day.

Can it be combined with other methods?

Yes — with physiotherapy and exercise therapy. NSAIDs are not recommended during active regeneration.